Azurity Pharmaceuticals, Inc. et al. v. Accord Healthcare, Inc.
Infringement action filed 31 Mar 2023 in the United States District Court for the District of Delaware and closed 21 Jun 2023, with US9050307B2 asserted. Recorded basis of termination: voluntary dismissal.
Case record
- Patent involved
- US9050307B2
- Application no.
- US14/003598
- Case no.
- 1:23-cv-00373
- Verdict cause
- Infringement action
- Court
- D. Del.
- Court level
- District Court
- Case region
- Delaware
- Chief judge
- Colm F. Connolly
- Trial level
- First instance
- Filed – Closed
- 31 Mar 2023 – 21 Jun 2023
- Duration
- 82 days
- Basis of termination
- Voluntary dismissal
- Products & marks
- Method for the preparation of a levothyroxine solution
- Validity challenges
- None recorded
Check this patent against your own product
Prior art, claim scope, infringement exposure and design-around routes. Every answer cites the records behind it.
Get an FTO claim chart- 01Ranked prior artEvery hit source-linked
- 02Claim-level comparisonAgainst your own product
- 03Legal statusAcross 174 jurisdictions
Method for the preparation of a levothyroxine solution
Levothyroxine, also known as L-thyroxine, synthetic T4, or 3,5,3′,5′-tetraiodo-L-thyronine, CAS number 51-48-9, is a synthetic form of thyroxine, used as a hormone substitute for patients with thyroid conditions. The invention relates to a method for the preparation of an oral levothyroxine composition. The method according to the invention results in liquid levothyroxine formulations that have improved storage stability compared to known liquid levothyroxine formulations.
- Legal status
- Active
- Granted
- 9 Jun 2015
- Est. expiry
- 6 Aug 2031
- Validity challenges
- None recorded
- Licences recorded
- None recorded
- Inventors
- PSARRAKIS, YANNIS · LIOUMIS, KONSTANTINOS I.
- Classification
- A61K31/198A61K9/08A61K31/055
- Prosecution counsel
- SCHWEGMAN LUNDBERG & WOESSNER, P.A.
- Examiner
- BASQUILL, SEAN
Parties of record
Azurity Pharmaceuticals, Inc.
- Core tech
- Not recorded
- Counsel
- Ian Robert Liston · Jennifer A. Ward · Jody Karol · Kristina M. Hanson · Wendy L. Devine
- Firm
- Wilson Sonsini Goodrich & Rosati PC
- Also named
- EMP Levo US, B.V.
Accord Healthcare, Inc.
- Core tech
- Not recorded
- Counsel
- Not recorded
- Firm
- Not recorded
Counsel of record
| Attorney | For | Role |
|---|---|---|
| Ian Robert Liston | Azurity Pharmaceuticals, Inc. | Plaintiff |
| Jennifer A. Ward | Azurity Pharmaceuticals, Inc. | Plaintiff |
| Jody Karol | Azurity Pharmaceuticals, Inc. | Plaintiff |
| Kristina M. Hanson | Azurity Pharmaceuticals, Inc. | Plaintiff |
| Wendy L. Devine | Azurity Pharmaceuticals, Inc. | Plaintiff |
Basis of termination
From the record · verbatim“Pursuant to Rule 41(a)(1)(A)(i) of the Federal Rules of Civil Procedure, Plaintiffs Azurity Pharmaceuticals, Inc. and EMP Levo US, B.V. hereby dismiss all claims asserted in this action without prejudice. At the time of filing this Notice of Dismissal, Defendant Accord Healthcare, Inc. has not served an answer or motion for summary judgment in this matter.”
Case 1:23-cv-00373 · D. Del. · closed 21 June 2023
Related cases
Three questions this record usually leads to. Each one runs against the full litigation and patent corpus, and cites what it finds.
Frequently asked questions
What is case 1:23-cv-00373?
1:23-cv-00373 is a patent infringement action brought by Azurity Pharmaceuticals, Inc. against Accord Healthcare, Inc., filed on 31 Mar 2023 in the United States District Court for the District of Delaware. The case closed on 21 June 2023.
Which patent was asserted in 1:23-cv-00373?
US9050307B2 (“Method for the preparation of a levothyroxine solution”), assigned to EMP LEVO US B.V., currently active. The record also lists Method for the preparation of a levothyroxine solution.
How was case 1:23-cv-00373 terminated?
The recorded basis of termination is voluntary dismissal. The termination text reads: “Pursuant to Rule 41(a)(1)(A)(i) of the Federal Rules of Civil Procedure, Plaintiffs Azurity Pharmaceuticals, Inc. and EMP Levo US, B.V. hereby dismiss all claims asserted in this action without prejudice. At the time of filing this Notice of Dismissal, Defendant Accord Healthcare, Inc. has not served an answer or motion for summary judgment in this matter.”
What does dismissal without prejudice mean?
A dismissal without prejudice ends this action but leaves the claims alive — the plaintiff may file them again later, subject to the limitation period.
How long did case 1:23-cv-00373 take?
82 calendar days, from filing on 31 Mar 2023 to closure on 21 June 2023.
Who were the attorneys and the judge in 1:23-cv-00373?
Chief Judge Colm F. Connolly presided. Ian Robert Liston, Jennifer A. Ward, Jody Karol, Kristina M. Hanson and Wendy L. Devine are recorded as counsel for plaintiff Azurity Pharmaceuticals.
Disclaimer. This page reproduces publicly available court docket data for case 1:23-cv-00373 and is provided for general information and reference only. It is not legal advice and must not be relied upon as such.
Docket data has limits. Records are drawn from a snapshot and may lag the live docket. Sealed filings, amended complaints, counterclaims and post-closure motions may not be reflected. Party names, attorney names and firm affiliations are reproduced as recorded and may contain omissions. Where a field is absent from the record, this page marks it as not recorded rather than inferring a value.
No characterisation of the parties or the outcome. This page reports what the record contains. Nothing here should be read as an assertion that any party infringed, that any patent is valid or invalid, that any settlement occurred, or that any party prevailed.
No FTO or validity opinion. Nothing on this page constitutes a freedom-to-operate, novelty, validity or infringement opinion. Any decision touching a live patent dispute should be verified independently and reviewed with qualified patent counsel.